Japan· JP-2190016B1043

ポリスチレンスルホン酸カルシウム

A medicinal product containing ポリスチレンスルホン酸カルシウム, registered in Japan by 東洋製薬化成, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ポリスチレンスルホン酸カルシウムAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)

Active substance: ポリスチレンスルホン酸カルシウム
Manufacturer: 東洋製薬化成
Country: Japan (JP)
ATC code: —
Reimbursed: Yes
Source register: MHLW / PMDA (Japan)
Last checked: September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ポリスチレンスルホン酸カルシウム in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ポリスチレンスルホン酸カルシウム products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Belgium · Kayexalate Calcium
Czechia · Resical
Germany · Elutit-Calcium
Denmark · Resonium Calcium
Estonia · Sorbisterit
Spain · Resincalcio
France · Resikali
United Kingdom (Northern Ireland) · Calcium Polystyrene Sulfonate, Calcium Polystyrene Sulfonate Roma Pharmaceuticals
Croatia · Xaviox
Ireland · Calcium Resonium
Italy · Sorbisterit
Luxembourg · Kayexalate Calcium
Netherlands · Calciumpolystyreensulfonaat Focus Care, Sorbisterit
Norway · Resonium-Calcium
Poland · Calcium Resonium
Portugal · Resical
Slovakia · Calcium Resonium, Sorbisterit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/02fdfa0f-250b-4e51-8b63-1983bf27e463
GET /v1/drugs/02fdfa0f-250b-4e51-8b63-1983bf27e463?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "９６．７％１ｇ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2190016B1043",
  "category": "内用薬",
  "price_yen": 6.9,
  "generic_name": "ポリスチレンスルホン酸カルシウム",
  "product_name_jp": null,
  "therapeutic_class": "2190",
  "transitional_expiry": "R9.3.31まで"
}

API reference MCP server Plans

See everything about ポリスチレンスルホン酸カルシウム.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console